Athenahealth

Athenahealth is not an investment firm. Corporate strategy, including M&A, is led by CEO Bob Segert and the executive team in coordination with the board, which includes representatives from current owners Hellman & Friedman and Bain Capital. Major capital allocation decisions, such as the DrFirst acquisition, are executed at the operating company level.

Athenahealth trades privately. It was taken off the public market in 2019 by Veritas Capital for $5.7 billion and then sold to Hellman & Friedman, Bain Capital, and GIC in March 2022 in a $17 billion transaction—the largest private-equity healthcare tech deal of that year. There has been no indication of a near-term re-listing.

Athenahealth operates as a cloud-native, multi-tenant network where all clients run on a single, continuously updated software instance. This stands in contrast to Epic's on-premise, client-specific installations. Athenahealth's architecture standardized regulatory updates and payer rule changes across its entire network simultaneously, turning the traditional healthcare IT upgrade cycle into a continuous operational feature.

Hellman & Friedman and Bain Capital led the 2022 consortium acquisition and hold majority control. Singapore's GIC is a minority co-investor. The ownership structure is typical of a sponsor-backed portfolio company, where the investors provide capital for growth and acquisitions while operational decisions remain with management.

Athenahealth primarily focuses on the ambulatory market: small to mid-sized physician practices, urgent care centers, and community hospitals. Its emergency department and urgent care modules serve hospital-affiliated settings, but it does not compete directly with Cerner or Epic for large inpatient academic medical center contracts.